Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Phillip K Darcy

Showing results (1-10 of 175) with videos related to

Pageof 18
Sort By:
Blood|May 27, 2008
IL-21 priming enhances T-cell immunotherapyPhillip K Darcy
Immunotherapy|June 13, 2015
Adoptive immunotherapy: a new era for the treatment of cancerPhillip K Darcy, Paul J Neeson
Clinical & Translational Immunology|August 2, 2019
CAR T cells take centre stagePaul A Beavis, Phillip K Darcy
Australian Family Physician|April 5, 2017
Immunotherapy of cancerJoseph A Trapani, Phillip K Darcy
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 18, 2015
Releasing the Brake on Oncolytic Viral TherapyClare Y Slaney, Phillip K Darcy
Immunology and Cell Biology|May 12, 2016
The double-edged sword of IFN-γ-dependent immune-based therapiesLiza B John, Phillip K Darcy
Current Opinion in Immunology|March 18, 2014
Editorial overview: Tumour immunology: New frontiers in cancer immunotherapyPhillip K Darcy, David S Ritchie
Cancer Immunology, Immunotherapy : CII|July 27, 2014
Foxp3 expression in T regulatory cells and other cell lineagesChristel Devaud, Phillip K Darcy, Michael H Kershaw
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 18, 2017
A Novel Target Antigen for the Treatment of Acute Myeloid Leukemia by CAR T CellsPaul A Beavis, Kevin Sek, Phillip K Darcy
Immunometabolism (Cobham, Surrey)|January 16, 2025
La dolce vita: fueling chimeric antigen receptor (CAR) T cells with Glut1 to improve therapeutic efficacyKaren Slattery, David K Finlay, Phillip K Darcy
Pageof 18

Showing results (1-10 of 175) with videos related to

Sort By:
Pageof 18
Blood|May 27, 2008
IL-21 priming enhances T-cell immunotherapyPhillip K Darcy
Immunotherapy|June 13, 2015
Adoptive immunotherapy: a new era for the treatment of cancerPhillip K Darcy, Paul J Neeson
Clinical & Translational Immunology|August 2, 2019
CAR T cells take centre stagePaul A Beavis, Phillip K Darcy
Australian Family Physician|April 5, 2017
Immunotherapy of cancerJoseph A Trapani, Phillip K Darcy
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 18, 2015
Releasing the Brake on Oncolytic Viral TherapyClare Y Slaney, Phillip K Darcy
Immunology and Cell Biology|May 12, 2016
The double-edged sword of IFN-γ-dependent immune-based therapiesLiza B John, Phillip K Darcy
Current Opinion in Immunology|March 18, 2014
Editorial overview: Tumour immunology: New frontiers in cancer immunotherapyPhillip K Darcy, David S Ritchie
Cancer Immunology, Immunotherapy : CII|July 27, 2014
Foxp3 expression in T regulatory cells and other cell lineagesChristel Devaud, Phillip K Darcy, Michael H Kershaw
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 18, 2017
A Novel Target Antigen for the Treatment of Acute Myeloid Leukemia by CAR T CellsPaul A Beavis, Kevin Sek, Phillip K Darcy
Immunometabolism (Cobham, Surrey)|January 16, 2025
La dolce vita: fueling chimeric antigen receptor (CAR) T cells with Glut1 to improve therapeutic efficacyKaren Slattery, David K Finlay, Phillip K Darcy
Pageof 18